CA2412373A1 - Method for enhancing bone mineral density gain - Google Patents

Method for enhancing bone mineral density gain Download PDF

Info

Publication number
CA2412373A1
CA2412373A1 CA002412373A CA2412373A CA2412373A1 CA 2412373 A1 CA2412373 A1 CA 2412373A1 CA 002412373 A CA002412373 A CA 002412373A CA 2412373 A CA2412373 A CA 2412373A CA 2412373 A1 CA2412373 A1 CA 2412373A1
Authority
CA
Canada
Prior art keywords
bisphosphonate
months
raloxifene
term
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002412373A
Other languages
English (en)
French (fr)
Inventor
Yili Lu
Douglas Boyer Muchmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2412373A1 publication Critical patent/CA2412373A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002412373A 2000-07-19 2001-07-05 Method for enhancing bone mineral density gain Abandoned CA2412373A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21928600P 2000-07-19 2000-07-19
US60/219,286 2000-07-19
US23373700P 2000-09-19 2000-09-19
US60/233,737 2000-09-19
PCT/US2001/016515 WO2002007733A2 (en) 2000-07-19 2001-07-05 Method for enhancing bone mineral density gain by administration of raloxifene

Publications (1)

Publication Number Publication Date
CA2412373A1 true CA2412373A1 (en) 2002-01-31

Family

ID=26913746

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002412373A Abandoned CA2412373A1 (en) 2000-07-19 2001-07-05 Method for enhancing bone mineral density gain

Country Status (5)

Country Link
EP (1) EP1307206A2 (de)
JP (1) JP2004504351A (de)
AU (2) AU2001272916A1 (de)
CA (1) CA2412373A1 (de)
WO (1) WO2002007733A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100479823C (zh) * 2001-12-21 2009-04-22 宝洁公司 双膦酸盐在制造药物套盒中的用途以及用于增加骨质的套盒
US20060173009A1 (en) * 2003-01-07 2006-08-03 Hiroyuki Kanoh Agent inducing increase in bone mass
KR100557086B1 (ko) * 2003-11-14 2006-03-03 한미약품 주식회사 랄록시펜과 비스포스포네이트의 상호 염
EP1715872A1 (de) * 2004-02-19 2006-11-02 Teva Pharmaceutical Industries Ltd. Verbesserte therapie unter verwendung einer kombination von raloxifen und alendronat
JP2008120702A (ja) * 2006-11-09 2008-05-29 Pola Chem Ind Inc 関節炎・関節症用の経口投与組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA41909C2 (uk) * 1994-07-22 2001-10-15 Елі Ліллі Енд Компані Використання комбінації сполук для інгібірування остеопорозу, фармацевтичний препарат

Also Published As

Publication number Publication date
AU2001272916A1 (en) 2002-02-05
JP2004504351A (ja) 2004-02-12
AU7291601A (en) 2002-02-05
EP1307206A2 (de) 2003-05-07
WO2002007733A2 (en) 2002-01-31
WO2002007733A3 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
EP0693285B1 (de) Bisphosphonat und anti-Resorption Agentien, enthaltende Zusammensetzungen zur Hemmung der Knochenschwund
USRE39050E1 (en) Methods of use for inhibiting bone loss and lowering serum cholesterol
EP0771200B1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
CZ281913B6 (cs) Použití derivátu 2-fenyl-3-aroylbenzothiofenu pro výrobu farmaceutického prostředku proti ztrátě k ostní hmoty a farmaceutický prostředek, který ten to derivát obsahuje
EP0659417B1 (de) Hemmung von dysfunctionalen Uterusblutungen
HUT71477A (en) Pharmaceutical compositions for increasing libido in post-menopausal women containing 2-phenyl-3-aroil-benzothiophene derivatives and process for their preparation
US5550123A (en) Methods for inhibiting bone prosthesis degeneration
CA2412373A1 (en) Method for enhancing bone mineral density gain
US5545661A (en) Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
US20030216358A1 (en) Method for enhancing bone mineral density gain
US5547685A (en) Methods for inhibiting bone loss with vanadyl sulfate
EP0769945B1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
EP0897722A1 (de) Benzo(b)thiophene Derivaten zur Hemmung von fibrösen entzündlichen Erkrankungen und Riedel-Schilddrüsenentzündung
EP0898966A1 (de) Benzo(b)thiophene Derivaten zur Hemmung von Kiefergelenkkrankheiten

Legal Events

Date Code Title Description
FZDE Dead